Kura Oncology Quarterly Balance Sheets Chart
Quarterly
|
Annual
Kura Oncology Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2010-12-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||||||
| current assets | |||||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 81,948,000 | 51,269,000 | 224,462,000 | 49,480,000 | 45,183,000 | 41,506,000 | 37,318,000 | 28,740,000 | 49,124,000 | 27,059,000 | 51,802,000 | 90,937,000 | 39,257,000 | 33,832,000 | 90,672,000 | 39,183,000 | 38,974,000 | 110,835,000 | 325,493,000 | 76,955,000 | 134,758,000 | 33,811,000 | 26,135,000 | 54,742,000 | 122,080,000 | 17,778,000 | 16,119,000 | 20,568,000 | 17,658,000 | 26,518,000 | 11,433,000 | 23,336,000 | 12,154,000 | 10,642,000 | 9,725,000 | 6,783,000 | 12,112,000 | 16,326,000 | 15,443,000 | 11,215,000 | 19,788,000 | 26,898 | 11,142 | 13,031 | 16,775 | 7,408 | 7,508 | 9,284 | |
| short-term investments | 548,780,000 | 606,922,000 | 502,933,000 | 405,817,000 | 446,336,000 | 485,616,000 | 386,639,000 | 423,853,000 | 427,855,000 | 378,841,000 | 386,183,000 | 336,838,000 | 411,001,000 | 446,243,000 | 427,288,000 | 504,262,000 | 528,520,000 | 493,038,000 | 307,827,000 | 248,458,000 | 204,111,000 | 183,124,000 | 210,756,000 | 195,384,000 | 139,333,000 | 147,747,000 | 162,866,000 | 166,855,000 | 108,227,000 | 111,682,000 | 81,712,000 | 77,469,000 | 41,090,000 | 48,511,000 | 58,065,000 | 67,785,000 | 67,978,000 | 62,140,000 | 70,303,000 | 30,017,000 | 26,145,000 | ||||||||
| receivable from contracts with collaborators | 4,574,000 | 48,746,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| prepaid expenses and other current assets | 24,773,000 | 17,261,000 | 17,434,000 | 7,892,000 | 8,249,000 | 10,713,000 | 8,524,000 | 7,324,000 | 8,667,000 | 10,550,000 | 8,441,000 | 8,616,000 | 9,528,000 | 6,959,000 | 4,329,000 | 5,460,000 | 6,138,000 | 6,832,000 | 3,972,000 | 3,498,000 | 3,317,000 | 4,164,000 | 2,682,000 | 2,775,000 | 2,380,000 | 1,882,000 | 1,988,000 | 2,737,000 | 2,420,000 | 1,904,000 | 1,280,000 | 909,000 | 1,187,000 | 1,134,000 | 725,000 | 886,000 | 1,045,000 | 1,203,000 | 693,000 | 695,000 | 884,000 | ||||||||
| total current assets | 660,075,000 | 724,198,000 | 744,829,000 | 463,189,000 | 499,768,000 | 537,835,000 | 432,481,000 | 459,917,000 | 485,646,000 | 416,450,000 | 446,426,000 | 436,391,000 | 459,786,000 | 487,034,000 | 522,289,000 | 548,905,000 | 573,632,000 | 610,705,000 | 637,292,000 | 328,911,000 | 342,186,000 | 221,130,000 | 239,603,000 | 252,948,000 | 263,904,000 | 167,586,000 | 181,197,000 | 190,392,000 | 128,535,000 | 140,361,000 | 94,641,000 | 101,923,000 | 54,735,000 | 60,628,000 | 68,810,000 | 75,715,000 | 81,421,000 | 80,075,000 | 86,869,000 | 42,306,000 | 47,189,000 | 54,627,000 | |||||||
| property and equipment | 3,912,000 | 2,348,000 | 1,682,000 | 1,315,000 | 1,523,000 | 1,709,000 | 1,859,000 | 2,057,000 | 2,253,000 | 2,370,000 | 2,540,000 | 2,734,000 | 2,546,000 | 2,567,000 | 2,673,000 | 2,731,000 | 2,300,000 | 2,069,000 | 2,021,000 | 2,103,000 | 1,652,000 | 805,000 | 44,000 | 1,000 | 5,000 | 10,000 | 17,000 | 24,000 | 32,000 | 40,000 | 47,000 | 55,000 | 62,000 | 71,000 | 78,000 | 59,000 | 34,000 | ||||||||||||
| operating lease right-of-use assets | 7,864,000 | 8,139,000 | 5,803,000 | 6,100,000 | 6,400,000 | 6,698,000 | 6,993,000 | 7,281,000 | 2,933,000 | 3,391,000 | 3,842,000 | 4,284,000 | 4,719,000 | 5,149,000 | 5,573,000 | 5,989,000 | 5,443,000 | 5,949,000 | 6,334,000 | 6,711,000 | 7,108,000 | ||||||||||||||||||||||||||||
| other long-term assets | 10,574,000 | 9,079,000 | 7,845,000 | 8,233,000 | 7,425,000 | 7,666,000 | 7,602,000 | 4,516,000 | 3,695,000 | 3,554,000 | 3,288,000 | 4,369,000 | 4,164,000 | 3,625,000 | 3,306,000 | 3,306,000 | 3,306,000 | 1,330,000 | 1,355,000 | 1,632,000 | 1,844,000 | 4,317,000 | 2,325,000 | 1,517,000 | 1,587,000 | 1,772,000 | 1,182,000 | 1,108,000 | 1,091,000 | 1,092,000 | 1,200,000 | 1,175,000 | 1,088,000 | 1,259,000 | 971,000 | 542,000 | 268,000 | 240,000 | 314,000 | 438,000 | 279,000 | 150,000 | |||||||
| total assets | 682,425,000 | 743,764,000 | 760,159,000 | 478,837,000 | 515,116,000 | 553,908,000 | 448,935,000 | 473,771,000 | 494,737,000 | 425,975,000 | 456,306,000 | 447,988,000 | 471,425,000 | 498,585,000 | 534,051,000 | 561,141,000 | 584,891,000 | 620,263,000 | 647,212,000 | 339,567,000 | 353,000,000 | 226,462,000 | 241,972,000 | 254,602,000 | 265,685,000 | 169,617,000 | 182,379,000 | 191,500,000 | 129,627,000 | 141,458,000 | 95,851,000 | 103,115,000 | 55,847,000 | 61,919,000 | 69,821,000 | 76,304,000 | 81,744,000 | 80,382,000 | 87,259,000 | 42,827,000 | 47,532,000 | 54,816,000 | 29,398 | 13,017 | 16,031 | 21,275 | 7,408 | 7,508 | 12,284 |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable and accrued expenses | 52,931,000 | 45,094,000 | 49,953,000 | 36,966,000 | 31,137,000 | 30,903,000 | 33,757,000 | 25,843,000 | 21,554,000 | 16,901,000 | 21,739,000 | 22,441,000 | 15,583,000 | 22,455,000 | 21,926,000 | 21,290,000 | 22,139,000 | 23,024,000 | 19,205,000 | 16,801,000 | 13,554,000 | 15,314,000 | 12,865,000 | 10,878,000 | 11,782,000 | 13,385,000 | 9,817,000 | 9,330,000 | 8,724,000 | 8,284,000 | 6,196,000 | 4,179,000 | 3,688,000 | 4,681,000 | 4,184,000 | 3,330,000 | 3,115,000 | 4,118,000 | 3,654,000 | 2,492,000 | 4,469,000 | 10,389 | 6,613 | 2,160 | 1,907 | 9,413 | 6,108 | 1,776 | |
| current operating lease liabilities | 1,696,000 | 1,905,000 | 1,881,000 | 1,691,000 | 1,467,000 | 1,363,000 | 1,506,000 | 1,682,000 | 2,345,000 | 2,332,000 | 2,318,000 | 2,304,000 | 2,290,000 | 2,276,000 | |||||||||||||||||||||||||||||||||||
| current portion of long-term debt | 3,112,000 | 1,921,000 | 2,607,000 | 1,715,000 | 847,000 | 3,000,000 | 3,000,000 | 2,500,000 | 1,750,000 | 1,000,000 | 250,000 | 2,834,000 | 2,813,000 | 2,294,000 | 1,531,000 | 1,024,000 | 500,000 | ||||||||||||||||||||||||||||||||
| current portion of contract liabilities | 49,435,000 | 40,846,000 | 24,271,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| total current liabilities | 107,174,000 | 89,766,000 | 78,712,000 | 40,372,000 | 33,451,000 | 32,266,000 | 35,263,000 | 27,525,000 | 23,899,000 | 19,233,000 | 24,057,000 | 24,745,000 | 17,873,000 | 17,725,000 | 22,455,000 | 21,926,000 | 21,290,000 | 25,139,000 | 26,024,000 | 21,705,000 | 18,551,000 | 14,554,000 | 15,564,000 | 13,112,000 | 11,232,000 | 12,143,000 | 13,615,000 | 12,905,000 | 12,580,000 | 11,351,000 | 10,031,000 | 7,562,000 | 5,076,000 | 4,116,000 | 5,451,000 | 5,272,000 | 4,384,000 | 4,310,000 | 5,055,000 | 4,711,000 | 3,604,000 | 5,531,000 | |||||||
| long-term debt, net of current portion | 6,509,000 | 7,650,000 | 6,916,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| long-term operating lease liabilities | 8,156,000 | 7,878,000 | 5,190,000 | 5,466,000 | 5,843,000 | 6,231,000 | 6,362,000 | 6,453,000 | 1,455,000 | 2,008,000 | 2,548,000 | 3,080,000 | 3,602,000 | 4,114,000 | 4,612,000 | 5,103,000 | 4,755,000 | 5,196,000 | 5,638,000 | ||||||||||||||||||||||||||||||
| other long-term liabilities | 2,595,000 | 2,139,000 | 1,795,000 | 1,471,000 | 1,176,000 | 951,000 | 705,000 | 567,000 | 461,000 | 351,000 | 265,000 | 542,000 | 459,000 | 496,000 | 375,000 | 356,000 | 295,000 | 441,000 | 395,000 | 344,000 | 306,000 | 2,207,000 | 377,000 | 406,000 | 372,000 | 385,000 | 279,000 | 556,000 | 500,000 | 446,000 | 388,000 | 336,000 | 279,000 | 223,000 | 170,000 | 58,000 | 27,000 | 101,000 | 332,000 | 604,000 | 391,000 | ||||||||
| long-term contract liabilities | 252,505,000 | 271,925,000 | 253,906,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| total liabilities | 376,939,000 | 379,358,000 | 346,519,000 | 55,066,000 | 49,046,000 | 48,824,000 | 51,662,000 | 43,834,000 | 35,059,000 | 30,792,000 | 36,028,000 | 28,367,000 | 21,934,000 | 22,335,000 | 27,442,000 | 27,385,000 | 26,340,000 | 34,276,000 | 36,307,000 | 33,072,000 | 30,626,000 | 23,261,000 | 23,191,000 | 21,018,000 | 19,104,000 | 20,052,000 | 21,394,000 | 16,893,000 | 17,230,000 | 16,658,000 | 15,986,000 | 13,916,000 | 12,210,000 | 11,678,000 | 12,945,000 | 12,638,000 | 11,703,000 | 4,316,000 | 5,156,000 | 5,043,000 | 4,208,000 | 5,922,000 | 70,389 | 31,613 | 27,160 | 26,907 | 9,413 | 6,108 | 1,776 |
| stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 10,000 shares authorized; no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 9,000 | 8,000 | 8,000 | 8,000 | 8,000 | 8,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 6,000 | 6,000 | 5,000 | 5,000 | 5,000 | 5,000 | 4,000 | 4,000 | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 1,000 | 1,000 | 1,000 | 500 | 500 | 500 | 500 | 500 | 500 | |
| additional paid-in capital | 1,323,739,000 | 1,316,275,000 | 1,308,290,000 | 1,298,852,000 | 1,288,326,000 | 1,276,856,000 | 1,119,976,000 | 1,112,118,000 | 1,104,944,000 | 1,003,949,000 | 997,111,000 | 964,724,000 | 957,489,000 | 948,312,000 | 941,359,000 | 934,168,000 | 925,796,000 | 919,258,000 | 913,354,000 | 582,608,000 | 574,385,000 | 434,722,000 | 431,322,000 | 428,259,000 | 425,035,000 | 313,220,000 | 310,849,000 | 308,366,000 | 231,120,000 | 228,759,000 | 169,201,000 | 167,752,000 | 112,866,000 | 111,647,000 | 110,748,000 | 110,162,000 | 109,577,000 | 108,975,000 | 108,484,000 | 57,604,000 | 57,069,000 | 57,040,000 | 49,500 | 49,500 | 49,500 | 49,500 | 49,500 | 49,500 | 49,500 |
| accumulated other comprehensive income | 711,000 | 974,000 | 764,000 | 1,116,000 | -1,789,000 | -194,000 | -393,000 | -82,000 | 46,000 | 224,000 | 557,000 | 561,000 | 331,000 | 332,000 | 161,000 | 18,000 | 11,000 | 45,000 | 11,000 | ||||||||||||||||||||||||||||||
| accumulated deficit | -1,018,973,000 | -952,851,000 | -895,422,000 | -876,205,000 | -821,801,000 | -770,964,000 | -721,439,000 | -678,653,000 | -640,051,000 | -602,877,000 | -568,808,000 | -535,694,000 | -500,190,000 | -465,421,000 | -432,968,000 | -400,225,000 | -366,859,000 | -333,196,000 | -302,502,000 | -276,343,000 | -252,574,000 | -232,087,000 | -212,877,000 | -195,012,000 | -178,620,000 | -163,677,000 | -149,737,000 | -133,640,000 | -118,633,000 | -103,894,000 | -89,290,000 | -78,542,000 | -69,209,000 | -61,389,000 | -53,856,000 | -46,509,000 | -39,583,000 | -32,922,000 | -26,296,000 | -19,822,000 | -13,732,000 | -8,147,000 | |||||||
| total stockholders’ equity | 305,486,000 | 364,406,000 | 413,640,000 | 423,771,000 | 466,070,000 | 505,084,000 | 397,273,000 | 429,937,000 | 459,678,000 | 395,183,000 | 420,278,000 | 506,609,000 | |||||||||||||||||||||||||||||||||||||
| total liabilities and stockholders’ equity | 682,425,000 | 743,764,000 | 760,159,000 | 478,837,000 | 515,116,000 | 553,908,000 | 448,935,000 | 473,771,000 | 494,737,000 | 425,975,000 | 456,306,000 | 534,051,000 | |||||||||||||||||||||||||||||||||||||
| commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||
| long-term debt | 7,757,000 | 8,576,000 | 9,376,000 | 9,332,000 | 9,289,000 | 9,244,000 | 9,200,000 | 9,158,000 | 3,500,000 | 4,250,000 | 5,000,000 | 5,750,000 | 6,500,000 | 7,250,000 | 7,500,000 | 7,500,000 | 7,500,000 | 7,500,000 | 3,432,000 | 4,150,000 | 4,861,000 | 5,567,000 | 6,018,000 | 6,855,000 | 7,339,000 | 7,324,000 | 7,308,000 | 7,292,000 | |||||||||||||||||||||
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive loss | -463,000 | -816,000 | -1,271,000 | -3,535,000 | -5,222,000 | -5,896,000 | -8,032,000 | -9,416,000 | -7,815,000 | -6,648,000 | -131,000 | -123,000 | -93,000 | -68,000 | -49,000 | -14,000 | -22,000 | -19,000 | -18,000 | ||||||||||||||||||||||||||||||
| restricted cash | 210,000 | 210,000 | 210,000 | 210,000 | 210,000 | 210,000 | 210,000 | 210,000 | 210,000 | 210,000 | 210,000 | 210,000 | 210,000 | 210,000 | |||||||||||||||||||||||||||||||||||
| liabilities and stockholders' equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders' equity: | |||||||||||||||||||||||||||||||||||||||||||||||||
| total stockholders' equity | 419,621,000 | 449,491,000 | 476,250,000 | 533,756,000 | 558,551,000 | 585,987,000 | 610,905,000 | 306,495,000 | 322,374,000 | 203,201,000 | 218,781,000 | 233,584,000 | 246,581,000 | 149,565,000 | 160,985,000 | 174,607,000 | 112,397,000 | 124,800,000 | 79,865,000 | 89,199,000 | 43,637,000 | 50,241,000 | 56,876,000 | 63,666,000 | 70,041,000 | 76,066,000 | 82,103,000 | 37,784,000 | 43,324,000 | 48,894,000 | -40,991 | -18,596 | -11,129 | -5,632 | -2,005 | 1,400 | 10,508 | ||||||||||||
| total liabilities and stockholders' equity | 447,988,000 | 471,425,000 | 498,585,000 | 561,141,000 | 584,891,000 | 620,263,000 | 647,212,000 | 339,567,000 | 353,000,000 | 226,462,000 | 241,972,000 | 254,602,000 | 265,685,000 | 169,617,000 | 182,379,000 | 191,500,000 | 129,627,000 | 141,458,000 | 95,851,000 | 103,115,000 | 55,847,000 | 61,919,000 | 69,821,000 | 76,304,000 | 81,744,000 | 80,382,000 | 87,259,000 | 42,827,000 | 47,532,000 | 54,816,000 | 29,398 | 13,017 | 16,031 | 21,275 | 7,408 | 7,508 | 12,284 | ||||||||||||
| accounts payable | 1,337,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| accrued expenses | 14,112,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| operating lease liabilities, long-term | 6,023,000 | 6,019,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable, related party | 31,000 | 30,000 | 47,000 | 111,000 | 179,000 | 224,000 | 232,000 | 230,000 | 257,000 | 216,000 | 209,000 | 304,000 | 341,000 | 295,000 | 261,000 | 286,000 | 406,000 | 430,000 | 379,000 | 372,000 | 349,000 | ||||||||||||||||||||||||||||
| other long-term assets, related party | 137,000 | 194,000 | 259,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | |||||||||||||||||||||||||||||||||||||||||
| accounts payable and accrued expenses, related party | 247,000 | 354,000 | 361,000 | 230,000 | 254,000 | 437,000 | 333,000 | 216,000 | 342,000 | 397,000 | 428,000 | 770,000 | 1,088,000 | 1,054,000 | 1,195,000 | 937,000 | 1,112,000 | ||||||||||||||||||||||||||||||||
| other long-term liabilities, related party | 24,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| long-term liabilities | 6,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| convertible notes payable, related party, current | |||||||||||||||||||||||||||||||||||||||||||||||||
| convertible notes payable, related party | |||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders' equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated comprehensive loss | -87,000 | -14,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable, related party | 1,057,000 | 1,062,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| accumulated comprehensive gain | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| cash | 53,571,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| prepaid expenses | 707,000 | 2,500 | 1,875 | 3,000 | 4,500 | 3,000 | |||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 10,000 shares authorized, no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||
| notes payable, stockholders | 60,000 | 25,000 | 25,000 | 25,000 | |||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||
| deficit accumulated during the development stage | -90,991 | -68,596 | -61,129 | -55,632 | -52,005 | -48,600 | -39,492 | ||||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.0001 par value; 10,000,000 shares authorized; | |||||||||||||||||||||||||||||||||||||||||||||||||
| no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||
| 5,000,000 shares issued and outstanding | 500 |
We provide you with 20 years of balance sheets for Kura Oncology stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Kura Oncology. Explore the full financial landscape of Kura Oncology stock with our expertly curated balance sheets.
The information provided in this report about Kura Oncology stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.